Why do people expect deals/partnerships/SP increase prior to these Phase 2 trials finishing up? The CDA's the company has been mentioning in PR's are about the results of the trials. To expect a deal prior to results is a little ridiculous, in my opinion.
Why would someone hold onto shares all through the beginning and middle of trials, then sell a couple of months before results? Why invest in a startup biotech if you're going to sell right before trials are finishing up??? I don't understand...